Author:
Stock Stephanie,Isselhard Anna,Shukri Arim,Kautz-Freimuth Sibylle,Redaèlli Marcus,Berger-Höger Birte,Dikow Nicola,Kiechle Marion,Köberlein-Neu Juliane,Meisel Cornelia,Schmutzler Rita,Steckelberg Anke,van Mackelenbergh Marion Tina,Vitinius Frank,Wöckel Achim,Rhiem Kerstin
Publisher
Deutscher Arzte-Verlag GmbH
Reference45 articles.
1. Kast K, Rhiem K, Wappenschmidt B, et al.: Prevalence of BRCA1/2 germline mutations in 21401 families with breast and ovarian cancer. J Med Genet 2016; 53: 465–71.
2. Hauke J, Horvath J, Groß E, et al.: Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer. Cancer Med 2018; 7: 1349–58.
3. Rhiem K, Bücker-Nott H, Hellmich M, et al.: Benchmarking of a checklist for the identification of familial risk for breast and ovarian cancers in a prospective cohort. Breast J 2019; 25: 455–60.
4. Kuchenbaecker KB, Hopper JL, Barnes DR, et al.: Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 2017; 317: 2402–16.
5. Bick U, Engel C, Krug B, et al. on behalf of the German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC): High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer. Breast Cancer Res Treat 2019; 175: 217–28.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献